Biosimilars play an important role in lowering net costs.
(Washington, D.C.) — Today, the Pharmaceutical Care Management Association (PCMA) announced the Virtual PBM Policy Forum 2021, featuring health care, pharmacy benefit managers (PBMs), and pharmaceutical manufacturer industry thought leaders and executives discussing how the public and private sectors are tackling
(Washington, D.C.) — In honor of World Diabetes Day, the Pharmaceutical Care Management Association (PCMA) has launched a new phase of the OnYourRxSide campaign that showcases how pharmacy benefit managers, PBMs, are working to improve the lives of patients living
(Washington, D.C.) — The Pharmaceutical Care Management Association’s (PCMA) podcast, The Pharmacy Benefit, released a new episode, “Understanding Prescription Drug Rebates.” The podcast episode, hosted by PCMA President and CEO JC Scott, features Alex Brill, a health policy researcher and founder
Upcoming Events Events 10 Nov 10 Nov – 11 Nov Test 2021-11-10 01:00 AM – 2021-11-11 03:00 AM Online Event PCMA Spring Webinar Series 2020 The live webinar series is designed to highlight drug supply chain executives’ thoughts and strategies
(Washington, D.C.) – The Pharmaceutical Care Management Association (PCMA) released the following statement on the Senate Finance Committee’s report on insulin pricing: “We appreciate the Senate Finance Committee’s focus on insulin pricing and share their urgency in addressing affordability and
(Washington, D.C.) — A highly consolidated insulin market limits competition and allows dramatic price increases on new and existing brand-name products, according to a new Visante analysis: “Insulins: Managing Costs with Increasing Manufacturer Prices.” The Visante analysis finds that insulin list prices escalated
New report from the Congressional Budget Office highlights the value of PBMs in keeping net drug costs low for payers and patients.
©2024 PCMA. All Rights Reserved.
